Ticker Details
Adaptive Biotechnologies Corporation
IPO Date:	June 24, 2019
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$3.49B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.68 | 3.75%
Avg Daily Range (30 D):	$0.84 | 4.71%
Avg Daily Range (90 D):	$0.55 | 3.53%

Institutional Daily Volume
Avg Daily Volume:	1.16M
Avg Daily Volume (30 D):	2.92M
Avg Daily Volume (90 D):	2.07M

Trade Size
Avg Trade Size (Sh.):	88
Avg Trade Size (Sh.) (30 D):	77
Avg Trade Size (Sh.) (90 D):	70

Institutional Trades
Total Institutional Trades:	3,203
Avg Institutional Trade:	$2.03M
Avg Institutional Trade (30 D):	$2.73M
Avg Institutional Trade (90 D):	$2.66M
Avg Institutional Trade Volume:	.12M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$2.62M
Avg Closing Trade (30 D):	$7.99M
Avg Closing Trade (90 D):	$5.02M
Avg Closing Volume:	159.87K

News

Jun 17, 2026 @ 5:21 PM Adaptive Biotechnologies Business Separation May U... Source: Vandana Singh

Jun 17, 2026 @ 10:00 AM Adaptive Biotechnologies Corporation Prices Upsize... Source: Na

Jun 16, 2026 @ 2:42 PM Adaptive Biotechnologies Stock Rises On Plan To Sp... Source: Vandana Singh

Jun 16, 2026 @ 12:49 PM Stock Market Today: S&P 500, Nasdaq Futures Fall, ... Source: Rishabh Mishra

Jun 14, 2026 @ 10:26 PM What Does an Adaptive Biotech Insider's Sale of Ne... Source: Robert Izquierdo

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$-.33	$-.13	$-.09
Diluted EPS	$-.33	$-.13	$-.09
Revenue	$295.41M	$70.87M	$71.68M
Gross Profit	$222.32M	$52.17M	$53.46M
Net Income / Loss	$-49.64M	$-20.02M	$-13.58M
Operating Income / Loss	$-46.73M	$-19.21M	$-12.77M
Cost of Revenue	$73.09M	$18.71M	$18.22M
Net Cash Flow	$26.93M	$7.11M	$15.46M
PE Ratio